PTPA and Alzheimer disease: The reduced methylation of PP2A C subunit at Leu309 and the increased phosphorylation of PP2A C subunit at Tyr307 may result in loss of enzymatic activity and tau hyper-phosphorylation in Alzheimer’s disease, indicating that PP2A is a putative target of therapeutic intervention[34].